Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
21.57
0.00 (0.00%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Xencor Employees
Xencor had 280 employees as of December 31, 2023. The number of employees decreased by 1 or -0.36% compared to the previous year.
Employees
280
Change (1Y)
-1
Growth (1Y)
-0.36%
Revenue / Employee
$477,207
Profits / Employee
-$633,450
Market Cap
1.51B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Teladoc Health | 5,600 |
Integra LifeSciences Holdings | 3,946 |
AMN Healthcare Services | 3,585 |
STAAR Surgical Company | 1,057 |
InMode | 581 |
Arcus Biosciences | 577 |
Dynavax Technologies | 408 |
Tarsus Pharmaceuticals | 244 |
XNCR News
- 19 days ago - Xencor Presents Preclinical Data on XmAb942, a High-Potency Extended Half-Life Anti-TL1A Antibody, to be Developed for Patients with Inflammatory Bowel Diseases - Business Wire
- 25 days ago - Xencor Announces Upcoming Change to Board of Directors - Business Wire
- 6 weeks ago - Xencor Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares - Business Wire
- 6 weeks ago - Xencor: Vudalimab Development Along With Hidden Gem Candidate - Seeking Alpha
- 6 weeks ago - Xencor Announces Pricing of $175 Million Public Offering of Common Stock - Business Wire
- 7 weeks ago - Xencor Announces Proposed Public Offering of Common Stock - Business Wire
- 7 weeks ago - Xencor Announces XmAb Drug Candidates in Autoimmune Disease with Near-Term Clinical Plans and Shares Clinical Progress in Early-Stage Oncology Programs - Business Wire
- 7 weeks ago - Xencor to Host Research & Development Webcast and Conference Call on Monday, September 9, 2024 - Business Wire